Kappa opiate binding sites in human placenta.
D000701:Analgesics, Opioid / Q000378:metabolism; D001667:Binding, Competitive; D002462:Cell Membrane / Q000378:metabolism; D003496:Cyclazocine / Q000031:analogs & derivatives / Q000378:metabolism; D016314:Ethylketocyclazocine; D005048:Etorphine / Q000378:metabolism; D005260:Female; D006801:Humans; D007700:Kinetics; D010920:Placenta / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D011247:Pregnancy; D011957:Receptors, Opioid / Q000378:metabolism*; D017473:Receptors, Opioid, kappa; D012964:Sodium / Q000494:pharmacology
D000701:Analgesics, Opioid; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; D005048:Etorphine; D016314:Ethylketocyclazocine; D012964:Sodium; D003496:Cyclazocine; D011188:Potassium